Benzinga | Nov 12, 2021 07:15AM EST

GlaxoSmithKline, Vir Biotech Report Primary Endpoint Was Met In COMET-TAIL Phase 3 Trial In Candidate For Treatment Of Intramuscular Admin. Of Sotrovimab

-Reuters-Reuters